Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

Allogeneic stem cell transplantation (SCT) from an HLA-haploidentical relative provides a potentially curative treatment option for hematologic malignancies patients who lack a suitably HLA-matched donor. The greatest challenge to performing HLA-haploidentical SCT has been high rates of graft failur...

Full description

Bibliographic Details
Main Authors: Munchel, Ashley, Kesserwan, Chimen, Symons, Heather J., Luznik, Leo, Kasamon, Yvette L., Jones, Richard J., Fuchs, Ephraim J.
Format: Online
Language:English
Published: PAGEPress Publications 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206539/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206539/

Similar Items